Taho Pharmaceuticals Ltd. Stock

Taho Pharmaceuticals Ltd a Taiwan-based company that mainly develops Transepithelial Delivery System (TDS) drug delivery technology. The Company absorbs small molecule drugs through the skin or transmucosal absorption, and the dosage forms include transdermal absorption patches, oral dissolving films and buccal dissolving films. The drugs include five major areas, including drugs for cardiovascular diseases, opium addiction withdrawal and overdose emergency drugs, cancer care, central nervous system drugs, and respiratory diseases. In addition to developing new dosage forms of drugs on its own, the Company also accepts commissions from major pharmaceutical companies or biotech companies to develop new dosage forms of products. New drugs under development include the TAH3311 orodispersible film and TAH3341 orodispersible film, TAH2231 buccal-dispersible film, generic drugs include TAH4411 orodispersible film, TAH9922 oral solution, the TAH2211 sublingual orodispersible film and others.